Related Experiment Video
Updated: Sep 26, 2025

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.4K
Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description
Paolo Castorina1,2, Gianluca Ferini3, Emanuele Martorana4
1INFN, Sezione di Catania, 95123 Catania, Italy.
Journal of Personalized Medicine
|April 23, 2022
Summary
We developed a quantitative algorithm to track tumor volume changes during and after radiochemotherapy. This method aids clinical decisions regarding treatment adjustments and surgical timing for cancer patients.
Area of Science:
- Oncology
- Medical Imaging
- Algorithm Development
Background:
- Tumor volume regression is crucial for guiding clinical decisions in cancer therapy.
- Quantitative assessment of treatment response can inform dose modification and surgical timing.
- Current methods may lack precise, patient-specific tracking of tumor volume dynamics.
Purpose of the Study:
- To develop and validate a macroscopic algorithm for quantitatively monitoring tumor volume changes over time.
- To assess the algorithm's utility in guiding treatment decisions during and after radiochemotherapy.
- To evaluate the algorithm's performance in preclinical models and clinical patient data.
Main Methods:
- Development of a macroscopic algorithm for quantitative tumor volume analysis.
- Validation of the algorithm using cell-line xenografts in mice.
- Application of the algorithm to patient data from radiochemotherapy trials.
Main Results:
- The algorithm successfully quantified tumor volume regression and evolution during and after treatment.
- Preclinical validation demonstrated the method's reliability.
- Successful application to patient data showed its clinical relevance for monitoring treatment response.
Conclusions:
- The proposed algorithm provides a quantitative, patient-oriented method for tracking tumor volume dynamics.
- This tool can support clinical decision-making for optimizing cancer treatment strategies.
- The algorithm shows promise for personalized cancer care and treatment response evaluation.

